Navigation Links
Accelerating Drug Development Through Drug & Companion Diagnostic Co-development, New Life Science Webinar Hosted by Xtalks
Date:10/2/2013

Toronto, Canada (PRWEB) October 02, 2013

The past decade has seen a transition from the traditional model of drug development to a more targeted, personalized approach to drug development and clinical trial design. The use of a companion diagnostic strategy is increasingly an essential component of the drug development process where it facilitates optimal patient stratification and outcome management. Parallel development of the drug and its companion diagnostic assay affords simplified logistics, economies of scale and the potential to accelerate the drug development process through optimal patient selection. The application of the companion diagnostic within the corresponding drug trial also provides valuable insight into the use of the companion diagnostic in a clinical setting and produces valuable data to support the regulatory filing of both the drug and the companion diagnostic.

Dr. Mark Roberts, Director of Diagnostic Development at Covance, will discuss the emerging field of companion diagnostics with focus on its importance in clinical trial design and how drug / companion diagnostic co-development is rapidly changing the drug development process.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtalks.com/Drug-and-Companion-Diagnostic-Co-Development.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11172002.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock
2. Patheon to Host Webinar on “Accelerating the Drug Development Trajectory by Improving Solubility of New Compounds”
3. Accelerating Drug Development by Harnessing Technology: New Life Science webinar Hosted by Xtalks
4. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
5. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
8. ZyGEM and USAMRIID Sign CRADA for Development of Simplified Sample Processing Solutions for Biothreat Agents
9. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
10. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
11. Idenix Reports Advancement of HCV Development Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 17, 2017 , ... LGC Maine Standards is ... calibration verification / linearity test kit. VALIDATE® SP2 evaluates Albumin, C-reactive protein, Haptoglobin, ... is prepared using the CLSI recommended “equal delta” method for linearity testing and ...
(Date:1/17/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... sales and earnings conference call will be broadcast live ... 8 a.m. Eastern Time.  A news release detailing the ... 7:30 a.m. Eastern Time the morning of the conference ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:1/17/2017)... 2017  Northwell Health today announced a collaboration ... cancer research. As ... provider, Northwell Health diagnoses and treats 19,000 new ... Germany -based oncology research company ... will greatly expand cancer biobanking activities within Northwell ...
(Date:1/17/2017)... Belgium (PRWEB) , ... January 17, 2017 , ... ... sample preparation and epigenetics research, recently announced a collaboration with the Heidelberg University ... DNA amplification method for library preparation, following the company’s successful launch of ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):